If your kidney markers spike after a particularly rough week of GI side effects , rehydrate aggressively and retest in 1-2 weeks before drawing conclusions
Published research has reported the following reference ranges: Preclinical (rodent) models: doses in the range of 0.13 nmol/kg administered at periodic intervals to evaluate pharmacokinetics, receptor activation, and metabolic signaling responses Early-phase clinical investigations: escalating dose protocols beginning at sub-milligram weekly doses, as reported in Phase 1 and Phase 2 trial literature (Coskun et al., 2022) In vitro systems: receptor binding and activation studies conducted at nanomolar concentrations to evaluate GLP-1R, GIPR, and GCGR engagement These values are model- and protocol-specific and do not translate directly to human use
Though each patient is unique, most will notice weight loss within the first month of treatment
Hu T, Yuan X, Ye R, Zhou H, Lin J, Zhang C, et al
